| AP | action potentials |
| APD | AP duration |
| ARDA | Atrial selective therapeutic agents |
| ChTx | Charybdotoxin |
| CMs | cardiomyocytes |
| EADs | probability of early afterdepolarizations |
| ERG | ether-á-go-go gene |
| ERP | effective refractory period |
| GOF | gain of function |
| hiAM | human immortalized atrial myocyte |
| iAM | immortalized atrial myocyte |
| IK,ACh | acetylcholine-sensitive inward rectifier potassium current |
| IKr | rapidly activating |
| IKs | slowly activating |
| IKur | ultra-rapidly activating |
| IL | Interleukin |
| Ito1 | the “transient outward” potassium current |
| Kv | voltage-gated potassium channels |
| KTx | potassium channel toxins |
| LOF | loss of function |
| MgTx | Margatoxin |
| PAH | pulmonary arterial hypertension |
| ProTx2 | Protoxin II |
| SPPS | solid-phase peptide synthesis |
| SR | sinus rhythm |
| TTX | tetrodotoxin |
| VGICs | Voltage-gated ion channels |
| Vmax | maximum speed of depolarization |
| VSD | voltage-sensing domain |
| VSP | voltage-sensing phosphatase |